A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

A new AI system from Mayo Clinic finds signs of the most common form of pancreatic cancer much earlier than standard ...

I’ve been poring over the news around Intellia Therapeutics’ NTLA-2001, an in vivo CRISPR-Cas9 therapy to inactivate the TTR gene in two sets of transthyretin amyloidosis patients. On October 27, 2025 ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.